Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Breast Carcinoma”

959 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 959 results

Not applicableStudy completedNCT00615901
What this trial is testing

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 38
Post-approval studies (Phase 4)Study completedNCT05365230
What this trial is testing

Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 261
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableActive Not RecruitingNCT04595435
What this trial is testing

IORT-Breast at Medical Center Navicent Health

Who this might be right for
Breast Cancer FemaleEarly-stage Breast Cancer
Wake Forest University Health Sciences 94
Not applicableStudy completedNCT00182728
What this trial is testing

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 89
Testing effectiveness (Phase 2)Study completedNCT00003992
What this trial is testing

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 200
Large-scale testing (Phase 3)Study completedNCT00049452
What this trial is testing

Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Herbert Irving Comprehensive Cancer Center 120
Large-scale testing (Phase 3)Looking for participantsNCT01185132
What this trial is testing

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

Who this might be right for
Breast Cancer
Rocky Mountain Cancer Centers 660
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Testing effectiveness (Phase 2)Ended earlyNCT05180006
What this trial is testing

Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 33
Testing effectiveness (Phase 2)Study completedNCT02789332
What this trial is testing

Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency

Who this might be right for
Breast CancerTriple Negative Breast NeoplasmsHRpos Breast Neoplasms+1 more
GBG Forschungs GmbH 107
Not applicableStudy completedNCT06299930
What this trial is testing

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy

Who this might be right for
Breast Cancer
Seoul National University Hospital 10,328
Testing effectiveness (Phase 2)UnknownNCT04997798
What this trial is testing

Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor Positive TumorHER2-positive Breast Cancer
First Affiliated Hospital of Zhejiang University 30
Not applicableNot Yet RecruitingNCT06474975
What this trial is testing

Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage Breast Cancer

Who this might be right for
Breast CancerBreast-conserving Surgery
European Institute of Oncology 150
Not applicableLooking for participantsNCT07354165
What this trial is testing

Financial Toxicity in Patients With Early-stage Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute, Naples 864
Not applicableStudy completedNCT04461977
What this trial is testing

Acupuncture for Peripheral Neuropathy Induced by Paclitaxel in Early Stage Breast Cancer

Who this might be right for
Peripheral Neuropathy Due to Chemotherapy
Instituto Brasileiro de Controle do Cancer 60
Large-scale testing (Phase 3)UnknownNCT06152471
What this trial is testing

Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer

Who this might be right for
Early-stage Breast CancerDiarrheaAdverse Drug Event
Henrik Lindman 100
Not applicableStudy completedNCT00544167
What this trial is testing

Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 45
Not applicableStudy completedNCT03568526
What this trial is testing

Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer

Who this might be right for
Peripheral NeuropathyStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+4 more
Ohio State University Comprehensive Cancer Center 36
Large-scale testing (Phase 3)Study completedNCT01598298
What this trial is testing

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

Who this might be right for
Breast CancerMusculoskeletal ComplicationsPain
SWOG Cancer Research Network 299
Load More Results